Soliton, Inc.

If you purchased Soliton, Inc. securities and would like to join the action, please click "Join This Action" below.

SOLITON MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF SOLITON, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – SOLY

May 10, 2021.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Soliton, Inc. (NASDAQ: SOLY) to Allergan Aesthetics for $22.60 per share in cash is fair to Soliton shareholders.

The investigation concerns whether Soliton and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Soliton shareholders; (2) determine whether Allergan Aesthetics is underpaying for Soliton; and (3) disclose all material information necessary for Soliton shareholders to adequately assess and value the merger consideration. On behalf of Soliton shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Scroll to Top